Lőrincz Hajnalka

1.

Sztanek, F., Lőrincz, H., Harangi, M., Nagy, A. C.: Incretin‐Based Therapies as Cardiometabolic Interventions: outcome Hierarchy, Receptor‐Network Pharmacology and Phenotype‐Based Clinical Positioning.
Diabetes Obes. Metab. [Epub ahead of print], 2026.

doi DEA WoS Scopus

Journal metrics:

D1 Endocrinology (2025)

D1 Endocrinology, Diabetes and Metabolism (2025)

D1 Internal Medicine (2025)

2.

Sztanek, F., Tóth, L., Hernyák, M., Pető, A., Lőrincz, H., Menyhárt, A., Balogh, D., Nagy, A. C., Kempler, P., Paragh, G., Harangi, M.: Targeting Oxidative Stress and Mitochondrial Dysfunction in Diabetic Neuropathy: Mechanisms and Therapeutic Opportunities.
Antioxidants. 15 (3), 367-401, 2026.

doi DEA WoS

Journal metrics:

Q1 Biochemistry (2025)

Q1 Cell Biology (2025)

Q1 Clinical Biochemistry (2025)

D1 Food Science (2025)

Q1 Molecular Biology (2025)

Q1 Physiology (2025)

3.

Katkó, M., Gazdag, A., Szentpéteri, A., Lőrincz, H., Galgóczi, E., Erdei, A., Berta, E., Bodor, M., Nagy, E. V., Harangi, M.: The Effect of Iatrogenic Hypothyroidism on Lipoprotein Subfractions and Markers of HDL Function in Patients with Differentiated Thyroid Carcinoma.
Life. 16 (7), 1-14, (article identifier: 1083), 2026.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2025)

Q1 Ecology, Evolution, Behavior and Systematics (2025)

Q1 Paleontology (2025)

Q2 Space and Planetary Science (2025)

4.

Mezei, K., Orosz, V., Horváth, I. F., Aradi, Z., Lőrincz, H., Harangi, M., Szántó, A.: The obesity paradox in primary Sjögren's disease: immunometabolic associations of chemerin, platelet count, and statin use.
Front. Immunol. 17, 1-11, 2026.

doi DEA

Journal metrics:

Q1 Immunology (2025)

Q1 Immunology and Allergy (2025)

5.

Diószegi, Á., Lőrincz, H., Molnár, Á., Kaluha, J., Homoródi, N., Katona, É., Harangi, M.: A betegség lefolyását módosító gyógyszeres kezeléssel szerzett tapasztalataink 2-es típusú diabetes mellitusos betegeinknél egy egycentrumos retrospektív vizsgálat eredményei alapján.
Diabetol. Hung. 33 (4), 319-332, 2025.

doi DEA

6.

Csiha, S., Hernyák, M., Molnár, Á., Lőrincz, H., Katkó, M., Paragh, G., Bodor, M., Harangi, M., Sztanek, F., Berta, E.: Alpha-Lipoic Acid Treatment Reduces the Levels of Advanced End Glycation Products in Type 2 Diabetes Patients with Neuropathy.
Biomedicines. 13 (2), 1-16, (article identifier: 438), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

7.

Ratku, B., Lőrincz, H., Csiha, S., Biró, L., Erdei, A., Berta, E., Ujvárosy, D., Bodor, M., Nagy, E. V., Szabó, Z., Harangi, M., Somodi, S.: Alterations of lipoprotein subfractions in GH-deficient adults.
Front Endocrinol (Lausanne). 16, 1-14, 2025.

doi DEA

Journal metrics:

Q1 Endocrinology, Diabetes and Metabolism

8.

Dániel, E., Harangi, M., Lőrincz, H.: A növekedési hormon/inzulinszerű növekedési faktor-1 tengely szerepe elhízásban és cukorbetegségben.
Lege Artis Med. 35 (9), 427-433, 2025.

doi DEA

Journal metrics:

Q4 Medicine (miscellaneous)

9.

Szinay, D., Szabó, K., Molnár, H., Béldi, T., Bencs, V., Lőrincz, H., Harangi, M., Griger, Z., Nagy-Vincze, M.: Assessment of Efficacy and Safety of Lipid-Lowering Treatment and Its Importance in Risk Assessment and Prevention in a Hungarian Myositis Cohort.
J Clin Med. 14 (10), 1-18, (article identifier: 3404), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

10.

Diószegi, Á., Lőrincz, H., Kaáli, E., Csiha, S., Kaluha, J., Varga, É., Páll, D., Tarr, T., Harangi, M.: Assessment of Serum Endocan Levels and Their Associations with Arterial Stiffness Parameters in Young Patients with Systemic Lupus Erythematosus.
J Clin Med. 14 (17), 1-16, (article identifier: 5955), 2025.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous)

11.

Nádró, B., Kaluha, J., Lőrincz, H., Varga, É., Balogh, I., Harangi, M.: Diagnostic and Therapeutic Challenges of Homozygous and Severe Heterozygous Familial Hypercholesterolemia from Clinical Aspect: A Single-Center Study.
J Clin Med. 14 (22), 1-15, (article identifier: 8058), 2025.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous)

12.

Reiber, I., Márk, L., Lőrincz, H., Együd, F., Mező, I., Paragh, G.: Goal Achievement in 3017 Patients at Very High Cardiovascular Risk Based on Different LDL Cholesterol Calculations and Non-HDL Cholesterol Levels: Shortcomings of the Use of Non-HDL Cholesterol as a Target Depending on Triglyceride Levels.
J. Clin. Med. 14 (14), 1-12, (article identifier: 5003), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

13.

Borbásné Sebestyén, V., Ujvárosy, D., Ratku, B., Lőrincz, H., Csiha, S., Tari, D., Majai, G., Somodi, S., Szűcs, G., Harangi, M., Szabó, Z.: Inflammatory Biomarkers and Lipid Parameters May Predict an Increased Risk for Atrial Arrhythmias in Patients with Systemic Sclerosis.
Biomedicines. 13 (1), 1-15, (article identifier: 220), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

14.

Paragh, G., Szentimrei, R., Harangi, M., Lőrincz, H.: Krónikus gyulladás és ateroszklerózis.
Metabolizmus. 23 (1), 27-33, 2025.

DEA

15.

Dániel, E., Sztanek, F., Csiha, S., Ratku, B., Somodi, S., Paragh, G., Harangi, M., Lőrincz, H.: Long-Term Effects of Semaglutide and Sitagliptin on Circulating IGFBP-1, IGFBP-3 and IGFBP-rp1: results from a One-Year Study in Type 2 Diabetes.
Int. J. Mol. Sci. 26 (21), 1-14, (article identifier: 10404), 2025.

doi DEA

Journal metrics:

Q1 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

16.

Rácz, L., Lőrincz, H., Seres, I., Kardos, L., Paragh, G., Csépány, T.: Modulation of Paraoxonase 1 Activity and Asymmetric Dimethylarginine by Immunomodulatory Therapies in Multiple Sclerosis.
Int. J. Mol. Sci. 26 (19), 1-14, (article identifier: 9728), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

17.

Tóth, L., Harsányi, A., Csiha, S., Molnár, Á., Lőrincz, H., Nagy, A. C., Paragh, G., Harangi, M., Sztanek, F.: Semaglutide Improves Lipid Subfraction Profiles in Type 2 Diabetes: insights from a One-Year Follow-Up Study.
Int. J. Mol. Sci. 26 (13), 1-18, (article identifier: 5951), 2025.

doi DEA WoS

Journal metrics:

Q1 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

18.

Sztanek, F., Pető, A., Tóth, L., Lőrincz, H., Molnár, Á., Lukács, M., Menyhárt, A., Kempler, P., Paragh, G., Harangi, M., Nagy, A. C.: Sex Differences in Cardiovascular Risk and Diabetic Polyneuropathy: a Single-Center Retrospective Study in North-Eastern Hungary.
J Clin Med. 14 (16), 1-16, (article identifier: 5780), 2025.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous)

19.

Lőrincz, H., Csiha, S., Ratku, B., Somodi, S., Sztanek, F., Paragh, G., Harangi, M.: Associations between Serum Kallistatin Levels and Markers of Glucose Homeostasis, Inflammation, and Lipoprotein Metabolism in Patients with Type 2 Diabetes and Nondiabetic Obesity.
Int. J. Mol. Sci. 25 (11), 1-12, (article identifier: 6264), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

20.

Szőke, C., Zsíros, N., Lőrincz, H., Paragh, G., Harangi, M.: Az Észak-Alföldi régió familiáris hypercholesterinaemiás betegeinek jellemzői: a familiáris hypercholesterinaemia regiszter jelentősége.
Lege Artis Med. 34 (5-6), 269-277, 2024.

doi DEA Scopus

Journal metrics:

Q4 Medicine (miscellaneous)

21.

Pető, A., Tóth, L. I., Hernyák, M., Lőrincz, H., Molnár, Á., Nagy, A. C., Lukács, M., Kempler, P., Paragh, G., Harangi, M., Sztanek, F.: Correlations between distal sensorimotor polyneuropathy and cardiovascular complications in diabetic patients in the North-Eastern region of Hungary.
Plos One. 19 (7), 1-13, (article identifier: 0306482), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Multidisciplinary

22.

Hernyák, M., Tóth, L., Csiha, S., Molnár, Á., Lőrincz, H., Paragh, G., Harangi, M., Sztanek, F.: Kallistatin as a Potential Marker of Therapeutic Response During Alpha-Lipoic Acid Treatment in Diabetic Patients with Sensorimotor Polyneuropathy.
Int. J. Mol. Sci. 25 (24), 1-14, (article identifier: 13276), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

23.

Berta, E., Halmi, S., Molnár, I., Hutkai, D., Csiha, S., Bhattoa, H. P., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E. V., Bodor, M.: Low Serum Fibroblast Growth Factor 21 Level and Its Altered Regulation by Thyroid Hormones in Patients with Hashimoto's Thyroiditis on Levothyroxine Substitution.
Metabolites. 14 (10), 1-10, (article identifier: 565), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q2 Endocrinology, Diabetes and Metabolism

Q2 Molecular Biology

24.

Paragh, G., Zilahi, P., Szentimrei, R., Lőrincz, H., Kolozsvári, L. R., Harangi, M.: Milyen kezelési lehetőségeink vannak a magas lipoprotein(a) csökkentésére?.
Metabolizmus. 22 (1), 16-22, 2024.

DEA

25.

Csengő, E., Lőrincz, H., Csősz, É., Guba, A., Kárai, B., Tóth, J., Csiha, S., Paragh, G., Harangi, M., Nagy, G. G.: Newly Initiated Statin Treatment Is Associated with Decreased Plasma Coenzyme Q10 Level After Acute ST-Elevation Myocardial Infarction.
Int. J. Mol. Sci. 26 (1), 1-18, (article identifier: 106), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy